[fcb5af]: / literature / by_gene / MYB.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 33611795 10.1002/gcc.22943 2022 MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia. MYB
2 34573335 10.3390/genes12091355 2022 Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia. MYB
3 34601571 10.1182/blood.2021013156 2022 Effective therapy for AML with RUNX1 mutation by cotreatment with inhibitors of protein translation and BCL2. MYB
4 35022522 10.1038/s41417-021-00421-6 2022 Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia. MYB
5 35091678 10.1038/s41388-021-02162-0 2022 An mRNA expression-based signature for oncogene-induced replication-stress. MYB
6 35205272 10.3390/genes13020227 2022 The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma. MYB
7 36072598 10.3389/fimmu.2022.974088 2022 MiR-150 in HTLV-1 infection and T-cell transformation. MYB
8 31885322 10.1080/15384101.2019.1706903 2021 The double dealing of cyclin D1. MYB
9 32420699 10.1002/cam4.3136 2021 Serine-227 in the N-terminal kinase domain of RSK2 is a potential therapeutic target for mantle cell lymphoma. MYB
10 32701692 10.1097/DAD.0000000000001632 2021 A Clinicopathological Study of 29 Spitzoid Melanocytic Lesions With ALK Fusions, Including Novel Fusion Variants, Accompanied by Fluorescence In Situ Hybridization Analysis for Chromosomal Copy Number Changes, and Both TERT Promoter and Next-Generation Sequencing Mutation Analysis. MYB
11 32732362 10.3324/haematol.2020.254276 2021 Genetic manipulation of primary human natural killer cells to investigate the functional and oncogenic roles of PRDM1. MYB
12 32779388 10.1111/ajco.13406 2021 v-myb avian myeloblastosis viral oncogene homolog expression is a potential molecular diagnostic marker for B-cell acute lymphoblastic leukemia. MYB
13 32868912 10.1038/s41423-020-00527-1 2021 Exploring the stage-specific roles of Tcf-1 in T cell development and malignancy at single-cell resolution. MYB
14 32878504 10.1080/03630269.2020.1811117 2021 Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions. MYB
15 33538126 10.1111/ijlh.13477 2021 Epigenetic analysis reveals significant differential expression of miR-378C and miR-128-2-5p in a cohort of relapsed pediatric B-acute lymphoblastic leukemia cases. MYB
16 33603066 10.1038/s41598-021-83613-2 2021 Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells. MYB
17 33884195 10.3892/br.2021.1428 2021 Regulation of gene transcription of B lymphoma Mo-MLV insertion region 1 homolog (Review). MYB
18 33930347 10.1016/j.bcp.2021.114576 2021 Berberine exerts anti-tumor activity in diffuse large B-cell lymphoma by modulating c-myc/CD47 axis. MYB
19 33971281 10.1016/j.canlet.2021.04.027 2021 Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia. MYB
20 34212378 10.1111/bjh.17609 2021 Infant T-cell acute lymphoblastic leukaemia with t(6;7) (TCRB-MYB) translocation. MYB
21 34535769 10.1038/s41388-021-02012-z 2021 Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia. MYB
22 34588425 10.1038/s41420-021-00655-1 2021 The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis. MYB
23 30038718 10.18632/oncotarget.25707 2020 MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways. MYB
24 30112030 10.3892/etm.2018.6230 2020 The clinical significance of Mda-7/IL-24 and C-myb expression in tumor tissues of patients with diffuse large B cell lymphoma. MYB
25 30646895 10.1186/s12920-018-0469-0 2020 Regulatory network analysis reveals the oncogenesis roles of feed-forward loops and therapeutic target in T-cell acute lymphoblastic leukemia. MYB
26 31218974 10.1017/S0967199419000169 2020 Synergistic effect of basic fibroblast growth factor (bFGF) and epidermal growth factor on derivation of camel (<i>Camelus dromedarius</i>) trophoblast stem cells. MYB
27 31557894 10.3390/cancers11101427 2020 FOXO1 Confers Maintenance of the Dark Zone Proliferation and Survival Program and Can Be Pharmacologically Targeted in Burkitt Lymphoma. MYB
28 31628193 10.1074/jbc.RA119.010144 2020 DNA methyltransferase 1-mediated CpG methylation of the miR-150-5p promoter contributes to fibroblast growth factor receptor 1-driven leukemogenesis. MYB
29 31648321 10.1182/bloodadvances.2019000404 2020 Transcriptome analysis offers a comprehensive illustration of the genetic background of pediatric acute myeloid leukemia. MYB
30 31719683 10.1038/s41375-019-0628-0 2020 Physiological levels of the PTEN-PI3K-AKT axis activity are required for maintenance of Burkitt lymphoma. MYB
31 31882553 10.21873/cgp.20169 2020 BRD4-Regulated Molecular Targets in Mantle Cell Lymphoma: Insights into Targeted Therapeutic Approach. MYB
32 32526730 2020 T-Cell Acute Lymphoblastic Leukemia: A Cytogenomic Update. MYB
33 32565969 10.3892/ol.2020.11583 2020 Pathogenesis of pediatric B-cell acute lymphoblastic leukemia: Molecular pathways and disease treatments. MYB
34 28394181 10.1080/10428194.2017.1292357 2019 A novel recurrent copy number loss region on 6q23.3 in MDS-related myeloid malignancy patients with stable survival conditions. MYB
35 28959124 2019 Higher Expression of Activation-induced Cytidine Deaminase Is Significantly Associated with Merkel Cell Polyomavirus-negative Merkel Cell Carcinomas. MYB
36 29233926 10.1158/0008-5472.CAN-17-2644 2019 Targeting CDK6 and BCL2 Exploits the MYB Addiction of Ph<sup>+</sup> Acute Lymphoblastic Leukemia. MYB
37 29654272 10.1038/s41375-018-0110-4 2019 Identification of novel lncRNAs regulated by the TAL1 complex in T-cell acute lymphoblastic leukemia. MYB
38 29666007 10.1016/j.cancergen.2018.02.006 2019 Mutation analysis of therapy-related myeloid neoplasms. MYB
39 30031020 10.1016/j.yexmp.2018.07.009 2019 EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes. MYB
40 30078801 10.11406/rinketsu.59.899 2019 [Understanding of molecular pathogenesis of T-cell leukemia by super-enhancer profiling]. MYB
41 30289070 10.2174/1566524018666181004121604 2019 Genetic Modifiers of Fetal Haemoglobin (HbF) and Phenotypic Severity in β-Thalassemia Patients. MYB
42 30308041 10.1371/journal.pone.0205537 2019 NKL homeobox gene activities in B-cell development and lymphomas. MYB
43 27307595 10.1158/1078-0432.CCR-15-1739 2018 Dysregulation of c-Myb Pathway by Aberrant Expression of Proto-oncogene MYB Provides the Basis for Malignancy in Adult T-cell Leukemia/lymphoma Cells. MYB
44 28331227 10.1038/leu.2017.94 2018 ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma. MYB
45 28489605 10.18632/oncotarget.17383 2018 Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome. MYB
46 29328450 10.3892/mmr.2018.8387 2018 MYBL2 protects against H9c2 injury induced by hypoxia via AKT and NF‑κB pathways. MYB
47 29415639 10.1080/10245332.2018.1435046 2018 Low expression of Mda-7/IL-24 and high expression of C-myb in tumour tissues are predictors of poor prognosis for Burkitt lymphoma patients. MYB
48 27150054 10.1016/j.trsl.2016.04.001 2017 ON 01910.Na inhibits growth of diffuse large B-cell lymphoma by cytoplasmic sequestration of sumoylated C-MYB/TRAF6 complex. MYB
49 27457538 10.1038/leu.2016.170 2017 c-myb hyperactivity leads to myeloid and lymphoid malignancies in zebrafish. MYB
50 27607579 10.1038/cddis.2016.267 2017 Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells. MYB
51 27659822 10.1007/s00381-016-3163-6 2017 An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an update. MYB
52 28260788 10.1038/leu.2017.75 2017 APOBEC signature mutation generates an oncogenic enhancer that drives LMO1 expression in T-ALL. MYB
53 28270453 10.1182/blood-2016-09-742148 2017 Activation of the <i>LMO2</i> oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia. MYB
54 28671688 10.1038/ng.3909 2017 The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia. MYB
55 28790107 10.1182/blood-2017-03-775536 2017 RUNX1 is required for oncogenic <i>Myb</i> and <i>Myc</i> enhancer activity in T-cell acute lymphoblastic leukemia. MYB
56 29099869 10.1371/journal.ppat.1006708 2017 Selection for avian leukosis virus integration sites determines the clonal progression of B-cell lymphomas. MYB
57 25924238 10.18632/oncotarget.3519 2016 Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia. MYB
58 26060891 10.1080/15548627.2015.1040970 2016 MYBL2 guides autophagy suppressor VDAC2 in the developing ovary to inhibit autophagy through a complex of VDAC2-BECN1-BCL2L1 in mammals. MYB
59 26206799 10.3324/haematol.2015.130179 2016 Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia. MYB
60 26500265 10.3382/ps/pev289 2016 Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line. MYB
61 26670384 10.1128/mBio.01863-15 2016 Common Viral Integration Sites Identified in Avian Leukosis Virus-Induced B-Cell Lymphomas. MYB
62 26862517 10.22074/cellj.2016.3808 2016 MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin. MYB
63 27456405 10.3109/10428198909042456 2016 Constitutive Expression of Multiple Cellular Oncogenes in Acute Myeloid Leukemia Cells. MYB
64 27458673 10.3109/10428199109068065 2016 C-Jun is Induced to High Continuous Expression During Differentiation of Hematopoietic Cells and is Regulated Independently from C-Fos. MYB
65 25193702 10.1016/j.bbrc.2014.08.131 2015 Piperlongumine inhibits the proliferation and survival of B-cell acute lymphoblastic leukemia cell lines irrespective of glucocorticoid resistance. MYB
66 25231743 10.1038/leu.2014.276 2015 MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia. MYB
67 25325875 10.3109/08820538.2014.959196 2015 Avoiding the major complication of ophthalmic pathology: misdiagnosis. A review of three common diagnostic challenges. MYB
68 25336632 10.1182/blood-2014-05-576470 2015 Opposing regulation of BIM and BCL2 controls glucocorticoid-induced apoptosis of pediatric acute lymphoblastic leukemia cells. MYB
69 25406379 10.1126/scisignal.2005500 2015 Characterization of a set of tumor suppressor microRNAs in T cell acute lymphoblastic leukemia. MYB
70 25541152 10.1038/leu.2014.351 2015 MicroRNAs in B-cell lymphomas: how a complex biology gets more complex. MYB
71 25948224 10.7534/j.issn.1009-2137.2015.02.051 2015 [Research Progress on Expression Regulation, Function and Clinical Significance of CASP8AP2 Gene]. MYB
72 23521217 10.1111/cas.12156 2014 Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro. MYB
73 23665184 10.1016/j.jhep.2013.04.031 2014 Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. MYB
74 23910958 10.1016/j.bcmd.2013.07.003 2014 GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas. MYB
75 23963825 10.1002/ajh.23570 2014 Downregulation of miR-15a due to LMP1 promotes cell proliferation and predicts poor prognosis in nasal NK/T-cell lymphoma. MYB
76 24149102 10.1038/ncomms3549 2014 Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma. MYB
77 24424791 10.1002/pbc.24803 2014 Prognostic implications of mutations in NOTCH1 and FBXW7 in childhood T-ALL treated according to the NOPHO ALL-1992 and ALL-2000 protocols. MYB
78 24586197 10.1371/journal.pgen.1004167 2014 Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc/p53-dependent bottleneck in lymphomagenesis. MYB
79 24613688 10.1016/j.yexmp.2014.02.015 2014 Low expression of miR-150 in pediatric intestinal Burkitt lymphoma. MYB
80 25394790 10.1126/science.1259037 2014 Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. MYB
81 23098454 10.7314/apjcp.2012.13.8.3681 2013 Transcription regulation network analysis of MCF7 breast cancer cells exposed to estradiol. MYB
82 23098478 10.7314/apjcp.2012.13.8.3825 2013 Combined study of cytogenetics and fluorescence in situ hybridization (FISH) analysis in childhood acute lymphoblastic leukemia (ALL) in a tertiary cancer centre in South India. MYB
83 23237561 10.1016/j.leukres.2012.11.009 2013 Piperlongumine inhibits proliferation and survival of Burkitt lymphoma in vitro. MYB
84 23246696 10.1016/j.gene.2012.12.009 2013 Regulation of the MIR155 host gene in physiological and pathological processes. MYB
85 23534754 10.7314/apjcp.2013.14.1.359 2013 Tax is involved in up-regulation of HMGB1 expression levels by interaction with C/EBP. MYB
86 23698072 10.1038/jid.2013.188 2013 Identification of multiple complex rearrangements associated with deletions in the 6q23-27 region in Sézary syndrome. MYB
87 23857984 10.1084/jem.20122516 2013 The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. MYB
88 23868181 10.1002/path.4239 2013 Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma. MYB
89 21544432 10.3892/ijo.8.4.815 2012 Oligonucleotides complementary to c-myb messenger RNA inhibit growth and induce apoptosis in human Burkitt lymphoma cells. MYB
90 21931777 10.1371/journal.pone.0024617 2012 Epstein-Barr virus-induced gene 3 (EBI3): a novel diagnosis marker in Burkitt lymphoma and diffuse large B-cell lymphoma. MYB
91 21948191 10.1093/intimm/dxr078 2012 Transcriptional control of T-cell development. MYB
92 22493372 2012 Expression and function of FRA2/JUND in cutaneous T-cell lymphomas. MYB
93 22516378 10.1016/j.mce.2012.03.024 2012 c-Myb interacts with the glucocorticoid receptor and regulates its level in pre-B-acute lymphoblastic leukemia cells. MYB
94 22764095 10.1002/ajh.23283 2012 Role of c-Myb in the survival of pre B-cell acute lymphoblastic leukemia and leukemogenesis. MYB
95 22829978 10.1038/bcj.2012.20 2012 Distinct regulation of c-myb gene expression by HoxA9, Meis1 and Pbx proteins in normal hematopoietic progenitors and transformed myeloid cells. MYB
96 22897851 10.1016/j.ccr.2012.06.007 2012 Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. MYB
97 20065082 10.3324/haematol.2009.010413 2011 Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults. MYB
98 21062812 10.1093/nar/gkq1043 2011 microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. MYB
99 21084380 10.1210/me.2010-0249 2011 A new, lineage specific, autoup-regulation mechanism for human glucocorticoid receptor gene expression in 697 pre-B-acute lymphoblastic leukemia cells. MYB
100 21252985 10.1038/leu.2010.317 2011 In vivo expression of an aberrant MYB-GATA1 fusion induces leukemia in the presence of GATA1 reduced levels. MYB